共 50 条
- [11] PPM1D Truncating Mutations Confer Chemotherapy Resistance in Hematopoietic Stem Cells, Which Is Reversible By PPM1D InhibitionBLOOD, 2016, 128 (22)Kahn, JosephineSilver, Alexander J.Mertins, PhilippCarr, StevenJaiswal, SiddharthaEbert, Benjamin L.
- [12] Unusual mutations in PPM1D linked to an increase in ovarian and breast cancerFUTURE ONCOLOGY, 2013, 9 (02) : 145 - 145Galukande, Natasha
- [13] Genetic variants and mutations of PPM1D control the response to DNA damageCELL CYCLE, 2013, 12 (16) : 2656 - 2664Dudgeon, CrissyShreeram, SathyavageeswaranTanoue, KanMazur, Sharlyn J.Sayadi, AhmedRobinson, Robert C.Appella, EttoreBulavin, Dmitry V.
- [14] Unusual mutations in PPM1D linked to an increase in ovarian and breast cancerEXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 121 - 121Galukande, Natasha
- [15] PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyCELL STEM CELL, 2018, 23 (05) : 700 - +Hsu, Joanne, IDayaram, TajhalTovy, AyalaDe Braekeleer, EtienneJeong, MiraWang, FengZhang, JianhuaHeffernan, Timothy P.Gera, SonalKovacs, Jeffrey J.Marszalek, Joseph R.Bristow, ChristopherYan, YuanqingGarcia-Manero, GuillermoKantarjian, HagopVassiliou, GeorgeFutreal, P. AndrewDonehower, Lawrence A.Takahashi, KoichiGoodell, Margaret A.
- [16] PPM1D Somatic Mutations in Myeloid Neoplasms: Clinical Profile, Clonal Characteristics and Impact of Concurrent Somatic TP53 MutationsBLOOD, 2024, 144 : 3218 - 3219Badar, TalhaEl Kettani, MobachirShah, Kashish J.Lasho, Terra L.Kusne, YaelFinke, Christy M.Foran, James M.Kharfan-Dabaja, Mohamed A.Murthy, Hemant S.Fan, Yao-ShanJiang, LiuyanGangat, NaseemaMangaonkar, Abhishek A.Al-Kali, ArefMarando, LudovicaTefferi, AyalewHe, RongViswanatha, DavidLitzow, Mark R.Patnaik, Mrinal M.
- [17] PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cellsBLOOD, 2018, 132 (11) : 1095 - 1105Kahn, Josephine D.Miller, Peter G.Silver, Alexander J.Sellar, Rob S.Bhatt, ShrutiGibson, ChristopherMcConkey, MarieAdams, DylanMar, BrentonMertins, PhilippFereshetian, ShauntKrug, KarstenZhu, HaolingLetai, AnthonyCarr, Steven A.Doench, JohnJaiswal, SiddharthaEbert, Benjamin L.
- [18] The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5qBLOOD, 2018, 132Panagiota, VictoriaMeggendorfer, ManjaKubasch, Anne SophieGabdoulline, RazifKroenke, JanShahswar, RabiaMies, AnnaKandziora, ChristianKlement, PiroskaSchiller, JohannesGoehring, GudrunHaferlach, ClaudiaGanster, ChristinaShirneshan, KatayoonGutermuth, AnnikaThiede, ChristianGerming, UlrichSchroeder, ThomasKobbe, GuidoKlesse, SabrinaKoenecke, ChristianSchlegelberger, BrigitteKroeger, NicolausHaase, DetlefDoehner, KonstanzeSperr, Wolfgang R.Valent, PeterGanser, ArnoldThol, FelicitasHaferlach, TorstenPlatzbecker, UweHeuser, Michael
- [19] PPM1D and DNMT3A Mutations in Myelodysplasia and Clonal HematopoiesisBLOOD, 2019, 134Motomura, MasanoriInoue, YoshikageNagata, YasunobuYoshizato, TetsuichiBaer, ConstanceMomozawa, YukihideNadarajah, NiroshanNannya, YasuhitoYoshida, KenichiHaferlach, ClaudiaKern, WolfgangAtsuta, YoshikoIijima-Yamashita, YukaShiraishi, YuichiOnizuka, MakotoChiba, KenichiTanaka, HirokoItonaga, HidehiroMiyazaki, YasushiHoribe, KeizoSanada, MasashiKamatani, YoichiroKubo, MichiakiMiyano, SatoruHaferlach, TorstenOgawa, SeishiMakishima, Hideki
- [20] Clinicopathologic Features of Patients with PPM1D Mutations: Myeloid Neoplasm Post Cytotoxic Therapy and De Novo Myeloid NeoplasmsLABORATORY INVESTIGATION, 2023, 103 (03) : S1134 - S1134Fisher-Campbell, NoraXie, WeiStreich, LukasMagallanes-Hoyos, M. CristinaTraer, ElieLi, PengDunlap, JenniferRaess, PhilWilliams, ToddPress, RichardFan, GuangWang, SaTang, GuilinWang, WeiSwords, RonanGandhi, ArpitaWiszniewska, Joanna